STRATEGY AND M&A WITH EXPERTISE IN CHINA AND SOUTHEAST ASIA

STRATEGY AND M&A WITH EXPERTISE IN CHINA AND SOUTHEAST ASIA

STRATEGY AND M&A WITH EXPERTISE IN CHINA AND SOUTHEAST ASIA

Health - Medtech, pharma, biotech, healthcare services

Dynamic growth in China and Southeast Asia

In China and Southeast Asia, healthcare provision still has some catching up to do compared to Western standards.

With rising purchasing power, healthcare provision in Asia is increasingly improving. Government programs such as “Healthy China” aim to significantly expand services while maintaining a high level of efficiency.

Western technologies and healthcare services can often support the objectives in Asia.

Projected Annual Growth MedTech until 2030
Source: MRL Advisors Research; Meta-Analysis
Project experience MRL Advisors in e.g.
  • Dental implants, dental technology
  • Endoscopy
  • Stents for aneurysms
  • Various diagnostic procedures incl. PCR
  • Imaging procedures (medical imaging)
  • Development of healthcare facilities
  • IT solutions for healthcare facilities
  • etc.
Illustration of MRL Advisors' experience in the healthcare sector
Featured Case
Interesting facts - Healthcare